NICE refuses Keytruda, Inlyta cancer combo

12th February 2020 Uncategorised 0

Despite evidence suggesting that the Keytruda combo would be welcomed by patients, NICE cites uncertainty around the long-term benefit.

More: NICE refuses Keytruda, Inlyta cancer combo
Source: News